Accessibility Menu
BioCube logo

BioCube(OTC) BICB

Market Cap$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-100%
1 Year-100%
1 Month-99%
$0.00
+0.00%
+0.00Today
BioCube last closing stock price
MetricPriceDate
Last closeUSD 0.002026-03-13
BioCube stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-02-27
1 month-99%USD 0.002025-12-22
3 month-99%USD 0.002025-12-11
Year to date-99%USD 0.002025-12-22
1 year-99.5%USD 0.002024-10-08
3 year-99.99%USD 0.012023-03-14
5 year-99.98%USD 0.012021-03-11
Since inception-100%USD 0.302009-08-27

BioCube Financials at a Glance

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$92.10K

Net Income (TTM)

-$63.59K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.49 (High)

Price

$0.00

Volume

40

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jan 1, 2025

BICB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioCube

BioCube, Inc. is an emerging company focused on the research, development, and commercialization of lithium-ion batteries across North America. Established in December 2010, BioCube operates from Bohemia, New York, and aims to innovate within the energy storage sector.

Products and Services
  • Development of advanced lithium-ion battery technology
  • Commercialization of energy storage solutions
  • Research initiatives aimed at improving battery efficiency
Growth Outlook
  • Recent quarterly revenue increased to $34,229 in Q3 2023
  • Quarterly cash flow from operations improved to $6,755 in Q3 2023
  • Significant potential in the growing lithium-ion battery market
Financial Highlights
  • Trailing twelve-month revenue of $99,102
  • Net income for Q3 2023 was -$5,171
  • Cash and cash equivalents reached $9,121 by Q3 2023
BioCube, Inc. is positioned in a rapidly expanding market, with a focus on lithium-ion battery technology that is critical for various applications, including electric vehicles and renewable energy storage. The company has shown a positive trend in revenue growth, with a notable increase in quarterly revenue and cash flow from operations. Despite reporting a net loss, the improvement in cash reserves indicates a strengthening financial position. The potential for growth in the energy storage sector presents an attractive opportunity for investors looking to engage with innovative companies in the technology space.
AI Generated • Jul 11, 2026

Industry

Electrical Equipment

CEO

Paul Lisak

Headquarters

Bohemia, NY 11716, US

BICB Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-116.78%

Return on Capital

N/A

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

96.74M

Volume

40

Avg. Volume

0

Financials (TTM)

Gross Profit

$92.10K

Operating Income

-$21.60K

EBITDA

$32.87K

Operating Cash Flow

$2.97K

Capital Expenditure

$0.00

Free Cash Flow

$2.97K

Cash & ST Invst.

$9.12K

Total Debt

$6.15K

BioCube Performance Analysis

BioCube annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-01-31USD 0N/A
20232023-01-31USD 0N/A
BioCube sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-01-31N/A
Q12023-04-30N/A
Q22023-07-31-4.7%
Q32023-10-3121.2%
BioCube annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-01-31USD 0.00N/A
20232023-01-31USD -0.00N/A
BioCube sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-01-3196.4%
Q12023-04-30-13720.6%
Q22023-07-3180.0%
Q32023-10-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$34.23K

N/A

Gross Profit

$34.23K

N/A

Gross Margin

100.00%

N/A

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.56

N/A

Employees

18

N/A

Net Income

-$5.17K

-1.1%

EBITDA

-$5.17K

-1.2%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Total Cash

$9.12K

N/A

Total Debt

$6.15K

N/A

Accounts Receivable

$1.77K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$6.15K

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

41.42%

N/A

Free Cash Flow

$6.76K

+249.7%

Operating Cash Flow

$6.76K

+249.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AAPTAll American Pet Company, Inc.
$0.00+9900.00%
CNHCChina Health Management Corp.
$0.00+0.00%
OOGIC2E Energy, Inc.
$0.00+0.00%
MYRXMyrexis, Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About BICB

What is the current price of BioCube?

BioCube is trading at $0.00 per share.

What is the 52-week range for BioCube?

Over the past 52 weeks, BioCube has traded between $0.00 and $0.00.

How much debt does BioCube have?

As of the most recent reporting period, BioCube reported total debt of $950.00.

How much cash does BioCube have on hand?

BioCube reported $0.00 in cash and cash equivalents in its most recent financial results.

What is BioCube’s dividend yield?

BioCube does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.